S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
Canada
TSX
Novo Resources Corp (NVO)
Novo Resources Corp (NVO) News

NVO

Novo Resources (NVO)

Novo Resources Corp

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:TSX:NVO

1 2 3 4 5 6 Next >>

Date	Time	Source	Headline	Symbol	Company
29/08/2023	02:14	PR Newswire (Canada)	Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NVO.WT	TSX:NVO	Novo Resources Corp
29/08/2023	02:10	PR Newswire (Canada)	Canadian Investment Regulatory Organization Trading Halt - NVO.WT	TSX:NVO	Novo Resources Corp
06/02/2021	01:00	PR Newswire (Canada)	TMX Group Equity Financing Statistics - January 2021	TSX:NVO	Novo Resources Corp
17/02/2010	00:00	PR Newswire (US)	Novo Nordisk Makes Victoza(R) Commercially Available in the United States	ASX:NVO
22/01/2010	07:49	PR Newswire (US)	Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'	ASX:NVO
14/01/2010	19:01	PR Newswire (US)	Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates	ASX:NVO
14/01/2010	01:43	PR Newswire (US)	/K I L L K I L L K I L L - National Changing Diabetes Program/	ASX:NVO
13/01/2010	16:01	PR Newswire (US)	Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates	ASX:NVO
03/12/2009	01:00	PR Newswire (US)	FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause	ASX:NVO
28/11/2009	01:30	PR Newswire (US)	Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows	ASX:NVO
27/11/2009	16:01	PR Newswire (US)	Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows	ASX:NVO
20/11/2009	00:00	PR Newswire (US)	Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show	ASX:NVO
31/10/2009	00:00	PR Newswire (US)	Novo Nordisk is Changing Possibilities in Hemophilia	ASX:NVO
20/10/2009	23:30	PR Newswire (US)	Data Analysis Reinforces the Safety Profile of Levemir(R)	ASX:NVO
01/09/2009	23:58	PR Newswire (US)	Research Supports Improving 'Scoring' of Costs and Benefits of Preventive Health Care to Better Inform Federal Budgetary Decisio	ASX:NVO
01/09/2009	22:00	PR Newswire (US)	National Changing Diabetes Program Supports Improvements in Health Cost Estimates	ASX:NVO
27/08/2009	23:03	PR Newswire (US)	Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families	ASX:NVO
13/08/2009	00:00	PR Newswire (US)	Dwayne Johnson, Novo Nordisk and the Entertainment Industry Foundation Educate Families about Healthy Living and Diabetes	ASX:NVO
10/08/2009	23:00	PR Newswire (US)	Photos: Norditropin NordiFlex(R) 30 mg/3 mL Prefilled Pen Offers Children Needing a Larger Dose of Growth Hormone a Convenient O	ASX:NVO
05/08/2009	22:30	PR Newswire (US)	Novo Nordisk Appoints Per Falk, M.D., Ph.D., as Vice President for Clinical, Medical and Regulatory Affairs for North America	ASX:NVO
23/07/2009	23:00	PR Newswire (US)	NCDP Health Care Reform Recommendations Advocate for Diabetes Prevention, Treatment and Care	ASX:NVO
16/07/2009	03:43	PR Newswire (US)	FDA Approves NovoLog(R) Labeling Update	ASX:NVO
14/07/2009	03:51	PR Newswire (US)	Diabetes Advocates Call For National Strategy, Leadership to Reduce Diabetes and Advance Detection and Treatment	ASX:NVO
29/06/2009	05:18	PR Newswire (US)	Novo Nordisk Insulin Analogs Have Proven Safety Profiles	ASX:NVO
14/06/2009	03:09	PR Newswire (US)	Novo Nordisk Warns Customers About Stolen Insulin	ASX:NVO
13/06/2009	00:25	PR Newswire (US)	Novo Nordisk Convenes Policy and Clinical Experts at Diabetes Media Summit	ASX:NVO
09/06/2009	07:50	PR Newswire (US)	The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide	ASX:NVO
08/06/2009	22:00	PR Newswire (US)	Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride	ASX:NVO
08/06/2009	00:00	PR Newswire (US)	Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride: Oral 162	ASX:NVO
21/05/2009	03:21	PR Newswire (US)	Americans Who Don't Know They Have Diabetes Incur $18 Billion in Health Expenses Each Year	ASX:NVO

Showing the most relevant articles for your search:TSX:NVO

1 2 3 4 5 6 Next >>

Thanachart Capital Public (PK)

Texas Gulf Energy (CE)

Goldman Sachs Just Us La...

Japan Fin. 23 A

Vaneurzonegovbd

Vaneck High Div

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions